{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T03:22:20Z","timestamp":1793762540448,"version":"4.6.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000965","name":"American Federation for Aging Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000965","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.clml.2021.08.001","type":"journal-article","created":{"date-parts":[[2021,8,12]],"date-time":"2021-08-12T04:24:06Z","timestamp":1628742246000},"page":"82-88","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Worsening Quality of Life in Indolent Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia Patients in Active Surveillance: A 12-Month Longitudinal Study"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2018-1860","authenticated-orcid":false,"given":"Kelly M.","family":"Trevino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Leonard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2021.08.001_bib0001","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1038\/leu.2014.91","article-title":"How we manage follicular lymphoma","volume":"28","author":"Hiddemann","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2021.08.001_bib0002","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/hon.2033","article-title":"Rituximab maintenance versus retreatment in follicular lymphoma","volume":"31","author":"Palla","year":"2013","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.clml.2021.08.001_bib0003","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1046\/j.1464-410X.2002.02846.x","article-title":"Is 'watchful waiting' a real choice for men with prostate cancer? A qualitative study","volume":"90","author":"Chapple","year":"2002","journal-title":"BJU Int"},{"key":"10.1016\/j.clml.2021.08.001_bib0004","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1093\/jnci\/djp123","article-title":"Impact of cancer on health-related quality of life of older Americans","volume":"101","author":"Reeve","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.clml.2021.08.001_bib0005","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00277-014-2161-6","article-title":"Impact of active surveillance, chlorambucil, and other therapy on health-related quality of life in patients with CLL\/SLL in the Netherlands","volume":"94","author":"van den Broek","year":"2015","journal-title":"Ann Hematol"},{"key":"10.1016\/j.clml.2021.08.001_bib0006","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1600-0609.2004.00233.x","article-title":"Quality of life of patients with chronic lymphocytic leukemia: Results of a longitudinal investigation over 1 yr","volume":"72","author":"Holzner","year":"2004","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.clml.2021.08.001_bib0007","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/10428194.2016.1190966","article-title":"FCR front-line therapy and quality of life in patients with chronic lymphocytic leukemia","volume":"58","author":"Kutsch","year":"2017","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2021.08.001_bib0008","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1080\/03007995.2020.1784120","article-title":"Health-related quality of life and economic burden of chronic lymphocytic leukemia in the era of novel targeted agents","volume":"36","author":"Waweru","year":"2020","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.clml.2021.08.001_bib0009","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/ejh.13503","article-title":"Quality of life in patients of chronic lymphocytic leukemia using the EORTC QLQ-C30 and QLQ-CLL17 questionnaire","volume":"105","author":"Youron","year":"2020","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.clml.2021.08.001_bib0010","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/abm\/kax004","article-title":"Cancer-specific stress and trajectories of psychological and physical functioning in patients with relapsed\/refractory chronic lymphocytic Leukemia","volume":"52","author":"Goyal","year":"2018","journal-title":"Ann Behav Med"},{"key":"10.1016\/j.clml.2021.08.001_bib0011","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1365-2141.2007.06791.x","article-title":"Quality of life in chronic lymphocytic leukemia: An international survey of 1482 patients","volume":"139","author":"Shanafelt","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2021.08.001_bib0012","doi-asserted-by":"crossref","first-page":"628","DOI":"10.3109\/10428191003587263","article-title":"Health-related quality of life in survivors of lymphoma: A systematic review and methodological critique","volume":"51","author":"Arden-Close","year":"2010","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2021.08.001_bib0013","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1188\/13.ONF.157-162","article-title":"Demographic and disease characteristics associated with non-hodgkin lymphoma survivors' quality of life: Does age matter?","volume":"40","author":"Leak","year":"2013","journal-title":"Oncol Nurs Forum"},{"key":"10.1016\/j.clml.2021.08.001_bib0014","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1007\/s00277-011-1274-4","article-title":"The impact of treatment, socio-demographic and clinical characteristics on health-related quality of life among Hodgkin's and non-Hodgkin's lymphoma survivors: A systematic review","volume":"90","author":"Oerlemans","year":"2011","journal-title":"Ann Hematol"},{"key":"10.1016\/j.clml.2021.08.001_bib0015","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1200\/JCO.2014.57.6801","article-title":"Anxiety and health-related quality of life among patients with low-tumor burden non-Hodgkin lymphoma randomly assigned to two different Rituximab dosing regimens: Results from ECOG trial E4402 (RESORT)","volume":"33","author":"Wagner","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clml.2021.08.001_bib0016","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S1470-2045(14)70027-0","article-title":"Rituximab versus a watch-and-wait approach in patients with advanced-stage, asymptomatic, non-bulky follicular lymphoma: An open-label randomised phase 3 trial","volume":"15","author":"Ardeshna","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clml.2021.08.001_bib0017","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.genhosppsych.2007.01.014","article-title":"Depression, anxiety and quality of life in a chronic lymphocytic leukemia cohort","volume":"29","author":"Levin","year":"2007","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1016\/j.clml.2021.08.001_bib0018","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.clml.2021.08.001_bib0019","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1136\/bmj.292.6516.344","article-title":"The hospital anxiety and depression scale","volume":"292","author":"Snaith","year":"1986","journal-title":"Br Med J"},{"key":"10.1016\/j.clml.2021.08.001_bib0020","first-page":"1241","article-title":"A review and recommendations for optimal outcome measures of anxiety, depression and general distress in studies evaluating psychosocial interventions for English-speaking adults with heterogeneous cancer diagnoses","volume":"18","author":"Luckett","year":"2010","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.clml.2021.08.001_bib0021","doi-asserted-by":"crossref","first-page":"487","DOI":"10.6004\/jnccn.2010.0035","article-title":"Short screening tools for cancer-related distress: A review and diagnostic validity meta-analysis","volume":"8","author":"Mitchell","year":"2010","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.clml.2021.08.001_bib0022","article-title":"The development and validation of a measure of health-related quality of life for non-Hodgkin's lymphoma: the functional assessment of cancer therapy\u2014lymphoma (FACT-Lym)","author":"Hlubocky","year":"2013","journal-title":"Lymphoma"},{"key":"10.1016\/j.clml.2021.08.001_bib0023","first-page":"1","article-title":"Dyadic coping of patients with hematologic malignancies and their partners and its relation to quality of life - A longitudinal study","author":"Ernst","year":"2016","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2021.08.001_bib0024","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1200\/JCO.1993.11.3.570","article-title":"The functional assessment of cancer therapy scale: development and validation of the general measure","volume":"11","author":"Cella","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clml.2021.08.001_bib0025","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3109\/10428194.2012.711830","article-title":"The functional assessment of cancer therapy - general (FACT-G) is valid for monitoring quality of life in patients with non-Hodgkin lymphoma","volume":"54","author":"Yost","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2021.08.001_bib0026","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/annonc\/mdx413","article-title":"ESMO Consensus Conference on malignant lymphoma: General perspectives and recommendations for the clinical management of the elderly patient with malignant lymphoma","volume":"29","author":"Buske","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clml.2021.08.001_bib0027","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1200\/JCO.2008.18.5850","article-title":"Patient anxiety about prostate cancer independently predicts early initiation of androgen deprivation therapy for biochemical cancer recurrence in older men: A prospective cohort study","volume":"27","author":"Dale","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clml.2021.08.001_bib0028","doi-asserted-by":"crossref","first-page":"e251","DOI":"10.1016\/S1470-2045(14)70215-3","article-title":"Rituximab for follicular lymphoma: Watch and wait, watch and worry, or watch and live?","volume":"15","author":"LeBlanc","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clml.2021.08.001_bib0029","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1200\/JCO.2011.40.6249","article-title":"Quality of life among long-term survivors of non-Hodgkin lymphoma: A follow-up study","volume":"31","author":"Smith","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clml.2021.08.001_bib0030","first-page":"241","article-title":"Are psychosocial factors associated with quality of life in patients with haematological cancer?","volume":"22","author":"Allart","year":"2013","journal-title":"crit rev literat. Psychooncol"},{"key":"10.1016\/j.clml.2021.08.001_bib0031","doi-asserted-by":"crossref","first-page":"972","DOI":"10.3109\/10428194.2011.563884","article-title":"Quality of life domains among non-Hodgkin lymphoma survivors: an integrative literature review","volume":"52","author":"Leak","year":"2011","journal-title":"Leuk Lymphoma"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265021003293?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265021003293?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:38:54Z","timestamp":1761871134000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265021003293"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S2152265021003293"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2021.08.001","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Worsening Quality of Life in Indolent Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia Patients in Active Surveillance: A 12-Month Longitudinal Study","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2021.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}